Antihypertensive Drugs Market By Type 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antihypertensive Drugs Market
Antihypertensive Drugs Market: By Type (Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, ARBs, Calcium Channel Blockers, Beta Blockers, Alpha Blockers, Vasodilators & Renin Inhibitors); – With Forecast (2016-2021)
Report Code : HCR 0143
Updated Date: 27 January, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Antihypertensive Drugs– Market Overview
2. Executive Summary 
3. Antihypertensive Drugs– Market Landscape 
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Antihypertensive Drugs– Market Forces
   4.1. Market Drivers 
   4.2. Market Constraints
   4.3. Market Challenges
   4.4. Attractiveness of the Antihypertensive Drugs Market 
      4.4.1. Power of Suppliers
      4.4.2. Power of Customers 
      4.4.3. Threat of New Entrants 
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. Antihypertensive Drugs Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Antihypertensive Drugs Market– By Type
   6.1. Diuretics
   6.2. Angiotensin Converting Enzyme (ACE) Inhibitors
   6.3. Angiotensin Receptor Blockers (ARBs)
   6.4. Calcium Channel Blockers
   6.5. Beta Blockers
   6.6. Alpha Blockers
   6.7. Vasodilators
   6.8. Renin Inhibitors 
7. Antihypertensive Drugs Market– By Geography
   7.1. Introduction
   7.2. Global Study
   7.3. Americas
      7.3.1. North America 
      7.3.2. Brazil
      7.3.3. Argentina
      7.3.4. Others 
   7.4. Europe
      7.4.1. U.K.
      7.4.2. France
      7.4.3. Germany
      7.4.4. Others
   7.5. APAC
      7.5.1. China
      7.5.2. Japan
      7.5.3. India
      7.5.4. Others
   7.6. ROW
8. Antihypertensive Drugs Market Entropy
   8.1. New Product Launches
   8.2. M&As, Collaborations, JVs and Partnerships
9. Company Profiles 
   9.1. Astra Zeneca Plc
   9.2. Daiichi Sankyo Company 
   9.3. Johnson & Johnson Ltd
   9.4. Lupin Limited
   9.5. Merck & Co
   9.6. Novartis AG
   9.7. Pfizer
   9.8. Ranbaxy Laboratories Limited
   9.9. Sanofi S.A
   9.10. Takeda Pharmaceutical Company 
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Expert Insights
   10.6. Disclaimer
Hypertension is a medical condition in which the blood pressure of an individual is elevated to a level beyond what is the desired level. As a result of this, a number of other conditions such as blood pressure and mental distress can take place. The number of cases of hypertension has grown exponentially in the last decade. Key reason for this has been the drastic change in lifestyle and diet intake. Within individuals working around the clock around different time zones, the required time for an individual to take rest is no longer sufficient. Individuals need plenty of sleep to recover and to be reenergized, however, exactly the opposite takes place with people not getting enough sleep, no exercise, no proper intake of healthy food all of which adds to hypertension in the long run.

Once the condition of hypertension has set in, the drugs which are required to keep this under control may be required for the rest of the individual’s life depending on the severity of the condition. In a way, this in itself is a case for the drug developers that there will always be a sustainable demand for the product. Hypertension is a condition which was recognized in the United States much ahead of many of the other regions with the antihypertensive drugs being sold right from day one in this country. There are also cases of a number of individuals taking these drugs as a preventive measure, as many doctors believe that the age group that this affects is slowly increasing in terms of range. Unless there are drastic lifestyle changes and changes in the diets of individuals, hypertension is expected to affect a vast volume of the working population over the next few years, especially in the APAC region with a number of companies and individuals working across different time zones.

Antihypertensive Drugs Market

The Antihypertensive Drugs market can be segmented on the basis of type as:
  • Diuretics
  • Angiotensin Converting Enzyme (ACE) Inhibitors
  • Angiotensin Receptor Blockers (ARBs)
  • Calcium Channel Blockers
  • Beta Blockers
  • Alpha Blockers
  • Vasodilators 
  • Renin Inhibitors 

The market has been segmented based on the following geographies:
  • North America
  • South America
  • APAC
  • Europe
  • Middle East 
  • Africa

Following are just a few of the companies that are operating in the Antihypertensive Drugs market:
  • Astra Zeneca Plc
  • Daiichi Sankyo Company
  • Johnson & Johnson Ltd
  • Lupin Limited 
  • Merck & Co
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports